Towards Healthcare
Drug Discovery Platforms Market Size Scales 13.44% CAGR by 2034

Drug Discovery Platforms Market Size, Trends and Strategic Collaborations

Based on market forecasts, the global drug discovery platforms market, projected at USD 186.24 million in 2024, is expected to reach USD 635.45 million by 2034, growing at a CAGR of 13.44% over the forecast period. Drug discovery platforms use smart tech to deliver drugs more safely and effectively. With rising chronic diseases and a push for personalized treatments, the market is booming led by North America, while Asia-Pacific is growing fastest. Antibodies and phage display lead the way.

Content

  • Insight Code: 5539
  • No. of Pages: 400
  • Format: PDF/PPT/Excel
  • Published: April 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

These platforms accelerate the drug development process by streamlining the identification of new drug candidates. They help researchers understand disease mechanisms, identify drug targets, and predict how drugs will interact with the body, ultimately reducing time and costs in bringing drugs to market.

Personalized medicine is driving drug discovery platforms to consider individual genetic and molecular profiles. This enables the development of more targeted and effective therapies, particularly for diseases like cancer, where treatment efficacy can vary greatly between patients.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, National Medical Products Administration.
Any Questions